Newsroom

PARIS--(BUSINESS WIRE)--Regulatory News: Sopra Steria (Euronext Paris: SOP), a major tech player in Europe, confident in its outlook and ability to create long term value, has announced a €40 million share buyback programme. Sopra Steria has appointed an independent investment services provider to execute a share buyback mandate for €40 million. The Company intends to retire the shares bought back. This share buyback programme was launched within the scope of the authorisation granted by the An...

PARIS--(BUSINESS WIRE)--Regulatory News: Sopra Steria (Euronext Paris : SOP), acteur majeur de la Tech en Europe, confiant dans ses perspectives et sa capacité à créer de la valeur à long terme, annonce le lancement d’un programme de rachat d’actions d’un montant de 40 M€. Sopra Steria a confié à un prestataire de services d’investissement indépendant un mandat de rachat d’actions portant sur un montant de 40 M€. Les actions ainsi rachetées sont destinées à être annulées. Ces rachats s’inscriro...

SOPHIA ANTIPOLIS, France--(BUSINESS WIRE)--Regulatory News: Median Technologies Launches a Capital Increase of €40 million, with Potential Upsize to €50 million, to Support the Deployment of eyonis® LCS in the U.S. and Europe and Advance New Clinical Indications for Its Proprietary eyonis® Pan-Cancer Early Diagnostics Suite NOT FOR DIRECT OR INDIRECT DISTRIBUTION IN OR INTO THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, SOUTH AFRICA OR JAPAN Median Technologies (FR0011049824, ALMDT, PEA-PME s...

SOPHIA ANTIPOLIS, France--(BUSINESS WIRE)--Regulatory News: Median Technologies lance une augmentation de capital d’un montant de 40 millions d’euros, pouvant atteindre 50 millions d’euros, afin de soutenir le déploiement d’eyonis® LCS aux États-Unis et en Europe et d’accélérer le développement de nouvelles indications cliniques pour sa plateforme propriétaire eyonis® de diagnostic précoce pan-cancer NE PAS DIFFUSER DIRECTEMENT OU INDIRECTEMENT AUX ETATS-UNIS D'AMERIQUE, AU CANADA, EN AUSTRALIE...

LOS ANGELES--(BUSINESS WIRE)--AMPL Investors Have Opportunity to Join Amplitude, Inc. Fraud Investigation with the Schall Law Firm...

SAN CARLOS, Calif.--(BUSINESS WIRE)--Acurex Biosciences, a biotechnology company developing new medicines for Parkinson’s disease and other neurological disorders, today announced it has been awarded a grant from Aligning Science Across Parkinson’s (ASAP) in partnership with The Michael J. Fox Foundation for Parkinson’s Research (MJFF). The award will support a multi-year collaboration, including Professor Sarah Marzi of King’s College London and Professor Emily Rocha of the University of Pitts...

美國加州聖荷西訊--(BUSINESS WIRE)--Rambus推出業界最快的DDR5 Client Chipset，搭載第二代Client時脈驅動器（CKD02）、PMIC5120與串行存在檢測集線器（SPD Hub），可實現高達9600 MT/s的突破性效能...

LONDON & NEW YORK & DUBLIN--(BUSINESS WIRE)--Corlytics sharpens its leadership for next phase of growth. Internationally experienced leader Lisa Miles-Heal is appointed Chief Executive Officer....

LOS ANGELES--(BUSINESS WIRE)--Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) (“Faraday Future”, “FF” or the “Company”), a California-based global Embodied AI (EAI) ecosystem company, today announced its participation in the New York special session of the World Leaders Forum, held on May 22, 2026 at the Sheraton LaGuardia East Hotel in Flushing, New York. The forum was organized under the leadership of Ms. Liya Rong, Dean and Co-Founder of Boston International Business School (BIBS), a...

香港--(BUSINESS WIRE)--(美國商業資訊)-- 作為在香港深耕逾 25 年的專業保險代理品牌，Kwiksure 快而保一直為不同駕駛者提供多家保險公司間的中立比較服務，為客戶揀選最合適的一站式汽車保險方案。憑藉多年專注車保市場的經驗，Kwiksure 深知港車北上的駕駛者在兩地往返時，最擔心的往往不是保費，而是保障是否足夠、理賠流程是否清晰可靠，因此 Kwiksure 快而保特別於廣州設立全新辦公室，為北上港車車主提供更貼心及貼身的保險體驗。 配合等效先認政策 周全保障簡單易明 配合現行的「等效先認」政策，Kwiksure 快而保為客戶提供「商業第三者責任保險，簡稱商業險險及「機動車交通事故責任強制保險，簡稱「交強險」」方案，讓港車北上時能同時滿足內地相關法定要求，並將複雜的跨境保險要求變得清晰易明，避免出現保障空隙或重複投保的風險。 跨境理賠「翻譯員」 清晰程序減低風險 在理賠及程序方面，Kwiksure 快而保更致力擔當中港之間的翻譯員角色，不單是語言上的翻譯，亦包括制度、流程及文件要求的「翻譯員」。無論是意外報案、索償文件準備，抑或與兩地保險公司、相關部門溝通，K...